Non-cognitive Adverse Effects of ECT

doi:10.1017/9781911623175.014

Chapter 14 - Non-cognitive Adverse Effects of ECT

Published online by Cambridge University Press: 27 June 2019

Jonathan Waite

Edited by

I. Nicol Ferrier and

Jonathan Waite

Show author details

I. Nicol Ferrier: Affiliation:
University of Newcastle upon Tyne
Jonathan Waite: Affiliation:
University of Nottingham

Book contents

Get access

Summary

Before effective treatments for depression were available many people admitted to hospital died. After the introduction of ECT, the proportion of patients in psychiatric hospitals with depression who died in hospital fell from about 15% to 2% (Slater, 1951). Although ECT is a potentially hazardous treatment, the alternatives are not free from risk (Coupland et al., 2011) and untreated depression carries a high morbidity and mortality.

Information

Type: Chapter
Information: The ECT Handbook , pp. 121 - 128

DOI: https://doi.org/10.1017/9781911623175.014 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Albin, S. M., Stevens, S. R. & Rasmussen, K. G. (2007) Blood pressure before and after electroconvulsive therapy in hypertensive and nonhypertensive Patients. Journal of ECT, 23, 9–10.CrossRef Google Scholar PubMed

American Psychiatric Association (2001) Adverse effects. In, The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging (2nd edn), pp. 59–76. APA.Google Scholar

American Society of Anesthesiologists (2014) ASA Physical Status Classification System http://www.asahq.org/quality-and-practice-management/practice-guidance-resource-documents/asa-physical-status-classification-system Google Scholar

Bailine, S., Fink, M., Knapp, R., et al. (2010) Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatrica Scandinavica, 121, 431–6.Google Scholar

Bay-Nielsen, M. & Kehlet, H. (2008) Anaesthesia and post-operative morbidity after elective groin hernia repair: a nation-wide study. Act Anaesthesilogia Scandinavica, 52, 169–74.Google Scholar PubMed

Blumberger, D. M., Seitz, D. P., Herrmann, N., et al. (2017) Low medical morbidity after acute courses of electroconvulsive therapy in a population based sample. Acta Psychiatrica Scandinavica DOI: 10.1111/acps.12815Google Scholar

Bruce, B., Henry, M. E. & Greer, D.H. (2006) Ischemic stroke after electroconvulsive therapy. Journal of ECT, 22, 150–2.Google Scholar

Coupland, C., Dhiman, P., Morriss, R., et al. (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343 :d4551doi: 10.1136/bmj.d4551CrossRef Google Scholar PubMed

Davison, D. L., Terek, M. & Chawla, L. S. (2012) Neurogenic pulmonary edema. Critical Care, 16, 212–19 doi:10.1186/cc11226Google Scholar

de Carle, A. J. & Kohn, R. (2001) Risk factors for falling in a psychogeriatric unit. International Journal of Geriatric Psychiatry, 16, 762–7.Google Scholar

Dennis, N. M., Dennis, P. A., Shafer, A., et al. (2017) Electroconvulsive therapy and all-cause mortality in Texas, 1998–2013. Journal of ECT, 33, 22–5.Google Scholar

Dinwiddie, S. H., Huo, D. & Gottlieb, O. (2010) The course of myalgia and headache after electroconvulsive therapy. Journal of ECT, 26, 116–20.Google Scholar

Food and Drug Administration (2006) Information for healthcare professionals. Selective serotonin reuptake inhibitors (SSRIs), selective serotonin-norepinephrine reuptake inhibitors (SNRIs), 5-hydroxytryptamine receptor agonists (triptans) 19 July. https://wayback.archive-it.org/7993/20170406044818/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085845.htm Google Scholar

Grunze, H., Vieta, E., Goodwin, G. M., et al. (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the Treatment of Acute Bipolar Depression. World Journal of Biological Psychiatry, 11, 81–109.Google Scholar

Hailey, E., Hodge, S. & Buley, N. (2015) ECTAS interim report, patient perspectives: March 2013–April 2014. Royal College of Psychiatrists http://rcpsych.ac.uk/pdf/ECTAS%20Interim%20Report.pdf Google Scholar

Kramer, B. A. (1999). Use of ECT in California, revisited: 1984–1994. Journal of ECT, 15, 245–51.Google Scholar

Leung, M., Hollander, Y. & Brown, G. R. (2003) Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. Journal of Clinical Psychiatry, 64, 551–3.Google Scholar

Mansoor, D., Trevino, S., Ganzini, L., et al. (2016) Negative pressure pulmonary edema after electroconvulsive therapy. Journal of ECT, 32, e2–e3.CrossRef Google Scholar PubMed

Markowitz, J. S., Kellner, C. H., de Vane, C. L., et al. (2001) Intranasal sumatriptan in post-ECT headache: results of an open-label trial. Journal of ECT, 17, 280–3.Google Scholar

Medda, P., Perugi, G., Zanello, S., et al. (2009) Response to ECT in bipolar I, bipolar II and unipolar depression. Journal of Affective Disorders, 118, 55–9.Google Scholar

Mizen, L., Morton, C. & Scott, A. (2015) The cardiovascular safety of the empirical measurement of the seizure threshold in electroconvulsive therapy. BJPsych Bulletin, 39, 14–18.Google Scholar

Munk-Olsen, T., Munk Laursen, T., Videbech, P., et al. (2007) All-cause mortality among recipients of electroconvulsive therapy. Register-based cohort study. British Journal of Psychiatry, 190, 435–9.Google Scholar

Nuttall, G. A., Bowersox, M. R., Douglass, S. B., et al. (2004) Morbidity and mortality in the use of electroconvulsive therapy. Journal of ECT, 20, 237–41.Google Scholar

Obbels, J., Verwijk, E., Bouckaert, F., et al. (2017) ECT-related anxiety: a systematic review. Journal of ECT, DOI: 10.1097/YCT.0000000000000383Google Scholar

Orlova, Y., Rizzoli, P. & Loder, E. (2018) Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurology, 75, 566–72.Google Scholar

Østergaard, S., Bolwig, T. & Petrides, G. (2014) No causal association between electroconvulsive therapy and death: a summary of a report from the Danish Health and Medicines Authority covering 99,728 treatments. Journal of ECT, 30, 263–4.Google Scholar

Povlsen, U. J., Wildschiødtz, G., Høgenhaven, H., et al. (2003) Nonconvulsive status epilepticus after electroconvulsive therapy. Journal of ECT 19, 164–9.CrossRef Google Scholar PubMed

Sackeim, H. A. (1998) The use of electroconvulsive therapy in late-life depression. In Geriatric Psychopharmacology (3rd edn) (ed. Salzman, C.), pp. 262–309. Williams & Wilkins.Google Scholar

Sarkar, S., Geraghty, J., Moore, A. R., et al. (2012) A multicentre study to determine the incidence, demographics, aetiology and outcome of 6-day emergency re-admission following day-case endoscopy. European Journal of Gastroenterology and Hepatology, 24, 1438–46.Google Scholar

Scottish ECT Accreditation Network (2016) Annual Report 2016: A Summary of ECT in Scotland for 2015. NHS National Services Scotland.Google Scholar

Sharp, R. P. & Welch, E. B. (2011) Takotsubo cardiomyopathy as a complication of electroconvulsive therapy. Annals of Pharmacotherapy, 45, 1559–65.Google Scholar

Shiwach, R. S., Reid, W. H. & Carmody, T. J. (2001) An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatric Services, 52, 1095–7.Google Scholar

Slater, E. (1951) Evaluation of electroconvulsive therapy as compared with conservative methods of treatment in depressive states. Journal of Mental Science, 97, 567–9.CrossRef Google Scholar

Tess, A. V. & Smetana, G. W. (2009) Medical evaluation of patients undergoing electroconvulsive therapy. New England Journal of Medicine, 360, 1437–44.Google Scholar

Tohen, M., Frank, E., Bowden, C. L., et al. (2009) The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders, 11, 453–73.CrossRef Google Scholar PubMed

Uppal, V., Dourish, J. & Macfarlane, A. (2010) Anaesthesia for electroconvulsive therapy. Continuing Education in Anaesthesia, Critical Care & Pain, 10, 192–6.Google Scholar

Watts, B. V., Groft, A., Bagian, J. P., et al. (2011) An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. Journal of ECT, 27, 105–8.Google Scholar

Weiner, R. D. & Krystal, A. D. (1993) EEG monitoring of ECT seizures. In, The Clinical Science of Electroconvulsive Therapy (ed. Coffey, C. E.), pp. 93–109. American Psychiatric Press.Google Scholar

Weiner, R. D., Coffey, C. E. & Krystal, A. D. (2000) Electroconvulsive therapy in the medical and neurologic patient. In, Psychiatric Care of the Medical Patient (2nd edn) (eds Stoudemire, B. S. Fogel, & Greenberg, D.), pp. 419–28. Oxford University Press.Google Scholar

Whittaker, R., Scott, A. & Gardner, M. (2007) The prevalence of prolonged cerebral seizures at the first treatment. Journal of ECT, 23, 11–13.Google Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.